Skip to content
Politically.com Search all
Menu

2026 · 1st Quarter (Jan 1 - Mar 31)

NRX PHARMACEUTICALS INC (FORMERLY KNOWN AS NEURORX)

Filed by TWENTY-FIRST CENTURY GROUP, INC..

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
1st Quarter - Report
Posted
Apr 17, 2026
Income
$24,000.00
Expenses
Not reported
Filing UUID
b56261e3-b50a-46d4-ad9c-b68c29de2ebf
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Research and treatment related to suicide prevention for veterans and patients with bipolar depression or PTSD.

MED · Medical/Disease Research/Clinical Labs

Research and treatment related to suicide prevention for veterans and patients with bipolar depression or PTSD.

VET · Veterans

Research and treatment related to suicide prevention for veterans and patients with bipolar depression or PTSD.

BUD · Budget/Appropriations

Research and treatment related to suicide prevention for veterans and patients with bipolar depression or PTSD within the Fiscal Year 2027 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Bill.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.